Histamine has been converted into a non-imidazole H-receptor histamine anta
gonist by addition of a 3-phenylbutyl group at the N-alpha-position followe
d by removal of the imidazole ring. The resulting compound, N-ethyl-N-(4-ph
enylbutyl)amine, remarkably has a K-i = 1.3 mu M as an H-3 antagonist. Usin
g this as a lead compound, a novel series of homologous O and S isosteric t
ertiary amines was synthesised and structure-activity studies furnished N-(
5-phenoxypentyl)pyrrolidine (K-i = 0.18 +/- 0.10 mu M, for [H-3]histamine r
elease from rat cerebral cortex synaptosomes) which, more importantly, was
active in vivo. Substitution of NO2 into the pam position of the phenoxy gr
oup gave N-(5-p-nitrophenoxypentyl)pyrrolidine, UCL 1972 (K-i = 39 +/- 11 n
M), ED50 = 1.1 +/- 0.6 mg/kg per as in mice on brain tele-methylhistamine l
evels.